Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 26, 2023, to report its financial results for the third quarter ended September 30, 2023. The key information is contained within the press release furnished as Exhibit 99.1. While the 8-K itself doesn't provide specific financial figures, it serves as the official notification and filing mechanism for the release of the company's quarterly performance data. Investors should refer to the press release (Exhibit 99.1) for detailed insights into BSX's revenue, earnings per share, segment performance, and any forward-looking guidance provided by the company. This filing is crucial for understanding the company's operational and financial standing during the third quarter of 2023 and its outlook for the remainder of the fiscal year.
Key Highlights
- 1Boston Scientific Corp (BSX) filed an 8-K on October 26, 2023.
- 2The filing pertains to the financial results for the third quarter ended September 30, 2023.
- 3The detailed financial results are provided in a press release furnished as Exhibit 99.1.
- 4This 8-K serves as a notification of the earnings release, with detailed financials contained within the exhibit.
- 5Investors are directed to Exhibit 99.1 for specific Q3 2023 financial performance data and commentary.
- 6The information is not deemed 'filed' for Section 18 purposes, a standard disclaimer for earnings release attachments.